CARBOPLATINO TEVA 10 mg/ml concentrato per soluzione per infusione clinical trials

Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlled trial (ECT-HN)

This study looks at a new way to treat certain mouth and throat cancers that have come back. It compares electrochemotherapy with a drug called bleomycin against a standard treatment mix. The goal is to see if the new method shrinks the cancer more effectively.